IL6 and COVID-19: After SARS-CoV-2 infection, vascular endothelial cells become dysfunctional and IL-6, TNF-a, and MCP-1 levels are elevated, leading to COVID-19-associated vascular inflammation and coagulopathy, particularly endotheliitis in the lungs, heart and kidney [27, 28].